长沙招聘

A) Main Responsibilities
1. Actively participate to the domestic partnership and cross border business governance
？ With CR999 (Our Chinese partners), lead the preparation and organization of key regular partnership committee meetings, including Joint Operation Committee to align operational matters & Executive Committee for key strategic decision makings.
？ On the cross border e-commerce side, assists the preparation and organization of quarterly reports and meetings with the GLT (global leadership team) and of regular governance meetings with the source countries.
？ For the domestic partnership, prepare Sanofi board member for due participation to the JV board decision, through effective communication with the partner and internal stakeholders
？ Drive the implementation of committee decisions and report on progress for both businesses
？ Make sure that the communication between CR999 & Sanofi is smooth and efficient. Contribute to e-mail translation and activate the informal communication to achieve business goals when needed.
？ Represent the face of Sanofi on the daily communication processes with CR999 (formal/informal).
？ Handle in complete autonomy projects given by the performance & governance manager.
？ Engage with senior stakeholders internally and externally in a convincing way.
？ PV ambassador: lead the Purpose and Value program of Sanofi China
？ Lead the update of the monthly newsletter to be sent to CR999 and internal stakeholders.
？ Assist the performance and governance manager in drafting more efficient and lean governance ways
2. Support the carry out of new NPD projects to broaden the content of domestic and cross-border businesses
？ Provide project management support to new M&A and NPD projects, including facilitating due diligence, supporting negotiation with partners, deal transition and execution, etc.
？ Communicate professionally and in a timely manner with internal and external stakeholders such as various internal work streams and potential business partners
？ Facilitate the negotiation and drafting of commercialization agreements with external partners on the new Sanofi leading brands to be launched in China
3. Provide proper contractual management to the domestic and cross-border businesses including the existing elements of the partnership with CR999, as well as other partners for cross-border, & future for both businesses
？ Ensure proper execution and conformity of practice with the existing Framework Agreement, JV Contracts and Exhibits, Essentiale Master Distribution and Promotion Agreements.
？ Similarly, ensure proper execution & conformity to agreements with cross-border distribution partners and platforms.
4. Help reviewing the one China strategy on a yearly basis
？ This should be done in collaboration with the performance analyst and the governance & performance manager.
B) Key Relationships
？ CHC China leadership team
？ CHC regional team and related CBEC teams across the world
？ Key dedicated supporting function teams: Finance, RA, Medical, ID&I
？ Key non-dedicated China based supporting function teams: IA, Supply Chain, Legal, HR, Compliance, Communication, PA
？ External: CR999 operational team, e-commerce partners
职位要求：
C) Ideal Experience
？ 1-3 years’ experience in Startup, Pharma, FMCG industry or consulting in China
？ Project management skills
？ Action and result oriented mindset
？ Good learning agility
？ Articulated and structured communication, best in class in both English and Chinese
？ Ability to work under pressure in a changing environment
？ Ability to challenge senior stakeholders
D) Required qualifications
？ Business or BD background
？ Consulting background

赛诺菲集团
赛诺菲集团是一家全球领先的多元化医药健康企业，专注于患者需求，传播健康。
 全球100,000余名员工，业务遍及100个国家
 新兴市场实力均衡，表现强劲，位列***
 多元领域，覆盖处方药、健康药业产品、疫苗和动物保健品
 疫苗领域的领导者
 领先动物保健市场
 2011年集团净销售额达334亿欧元

赛诺菲在中国
赛诺菲是首批在中国开设办事处的跨国制药集团，也是国内增长最快的医药健康企业之一。目前，赛诺菲在中国200多个城市拥有6000余名员工。
   
传承悠久历史、持续开拓进取
赛诺菲一直以来秉承对中国的承诺。1982年，赛诺菲成为首批在中国开设办事处的跨国制药企业之一。今天，赛诺菲已跻身中国医药健康市场的领军企业。赛诺菲的中国总部位于上海，并在北京、天津、沈阳、济南、上海、杭州、南京、武汉、成都、广州和乌鲁木齐共设11家区域办公室。

独特的医药健康产品系列、满足中国公共卫生需求
从预防到治疗，赛诺菲全方位满足中国的公共健康需求。集团的疫苗事业部赛诺菲巴斯德是中国领先的疫苗企业。赛诺菲在心血管/血栓、糖尿病、肿瘤、内科和中枢神经系统等关键的治疗领域拥有领先产品。2010年，杭州赛诺菲民生健康药业有限公司的成立标志着赛诺菲进入中国的非处方药市场。2011年2月，赛诺菲完成了对BMP太阳石的收购。

大幅投资工业建设、满足中国市场需求
赛诺菲目前在中国拥有六家生产基地，包括北京制药工厂、杭州制药工厂、杭州赛诺菲民生健康药业工厂、南昌梅里亚动物保健工厂、深圳赛诺菲巴斯德疫苗工厂、以及唐山健康药业工厂。

完善的研发架构、双赢的研发合作模式
在中国，赛诺菲具有从药物靶点发现到后期临床研究的整体研发实力。集团在上海设有中国研发中心和亚太研发中心，并在北京和成都分别设有研发机构。自2008年以来，赛诺菲与中国权威科研机构开展了10多项战略合作，在癌症、干细胞、糖尿病和老年疾病等前沿研究领域探索创新药物

依托于强劲的研发能力和多领域领先水平的广泛的医药产品资源，公司在中国的市场份额不断攀升，公司规模不断扩大，飞速发展的业务给了我们与更多优秀人才合作的机会。

如需了解更多信息，请访问*************


现在就行动！把握机遇，加入我们，您的职业生涯将与赛诺菲共同成长！抓住机会，来亲身体验我们所秉持的胆略、创新、团结、勇气的价值观。

请将您的中英文简历发给我们，并在email标题栏注明您所申请的职位名称。每个职位申请一次即可，请不要重复投递简历。谢谢！